Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection.
about
Forns index and 'FIB4' for staging of fibrosis in adults with chronic hepatitis CNon-invasive test of liver fibrosis for the diagnosis of oesophageal varices in patients with chronic liver disease or portal vein thrombosisNon-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?KASL clinical practice guidelines: management of hepatitis CChronic hepatitis C virus infection: Serum biomarkers in predicting liver damageLiver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact.Systematic review with meta-analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and BNon-invasive diagnosis of liver fibrosis and cirrhosis.Diagnostic Accuracy of APRI, AAR, FIB-4, FI, King, Lok, Forns, and FibroIndex Scores in Predicting the Presence of Esophageal Varices in Liver Cirrhosis: A Systematic Review and Meta-Analysis.Hepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antiviralsManagement before hepatectomy for hepatocellular carcinoma with cirrhosisNon-invasive diagnosis of liver fibrosis in chronic hepatitis CNon-invasive prediction of forthcoming cirrhosis-related complications.Non-alcoholic fatty liver disease: a practical approach to diagnosis and stagingNew Concepts on Pathogenesis and Diagnosis of Liver Fibrosis; A Review ArticleAlcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infectionsClinical Laboratory Testing in the Era of Directly Acting Antiviral Therapies for Hepatitis CNoninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.Unhealthy alcohol use, HIV infection and risk of liver fibrosis in drug users with hepatitis CNIKEI: a new inexpensive and non-invasive scoring system to exclude advanced fibrosis in patients with NAFLDThe VACS index accurately predicts mortality and treatment response among multi-drug resistant HIV infected patients participating in the options in management with antiretrovirals (OPTIMA) studyPredictive factors for sustained virological response after treatment with pegylated interferon α-2a and ribavirin in patients infected with HCV genotypes 2 and 3Diagnostic and Prognostic Values of Noninvasive Predictors of Portal Hypertension in Patients with Alcoholic CirrhosisDrug Authorization for Sofosbuvir/Ledipasvir (Harvoni) for Chronic HCV Infection in a Real-World Cohort: A New Barrier in the HCV Care CascadeHepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic StudyA new model using routinely available clinical parameters to predict significant liver fibrosis in chronic hepatitis BNew noninvasive index for predicting liver fibrosis in Asian patients with chronic viral hepatitis.Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy.Magnetic Resonance Elastography Shear Wave Velocity Correlates with Liver Fibrosis and Hepatic Venous Pressure Gradient in Adults with Advanced Liver Disease.Preoperatively staging liver fibrosis using noninvasive method in hepatitis B virus-infected hepatocellular carcinoma patients.Evaluation of APRI and FIB-4 for noninvasive assessment of significant fibrosis and cirrhosis in HBeAg-negative CHB patients with ALT ≤ 2 ULN: A retrospective cohort studyFibrosis assessment in patients with chronic hepatitis B virus (HBV) infection.Novel 3D Magnetic Resonance Elastography for the Noninvasive Diagnosis of Advanced Fibrosis in NAFLD: A Prospective Study.New combined parameter of liver and splenic stiffness as determined by elastography in healthy volunteersSerum hyaluronic acid predicts protein-energy malnutrition in chronic hepatitis C.Correlation of platelets count with endoscopic findings in a cohort of Egyptian patients with liver cirrhosis.Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study.Overestimate of Fibrosis by FIBROSpect® II in African Americans Complicates the Management of their Chronic Hepatitis CNoninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future Directions.Liver fibrosis markers of nonalcoholic steatohepatitis.
P2860
Q24188065-E63379BF-8336-429B-A83A-40A9181D5DA9Q24234751-F3CF36B4-49A2-434B-B746-369BA95B4CD2Q26744631-770FA5C2-0CC2-45DD-9EFC-EF186741C043Q26752471-08E73BFB-7BB5-4134-957F-A3AE32CAE823Q26773289-BB21B51D-A026-4B6F-BB0E-02D02F7C83E9Q26777511-9312A095-4186-478C-B023-E75E4112440AQ26777916-FAFA1ECA-970A-4030-AEC8-F8F400AAF033Q26778033-33951C6F-0D9D-40F0-8DF1-D80252A68D0AQ26779866-0EB8FDA7-FB27-4282-A317-B105ED661C13Q26782033-9D0FDAFF-1247-41CE-AB0C-B949D48519FEQ26783874-2DC919D3-D5F4-44DC-8026-AD5234EADBABQ26865956-FD3F0BF2-BC0C-41A0-B815-CB66E210C541Q27000645-DD2A1C46-3207-4743-A482-E0B24F371865Q27006131-4E297B91-37F3-4EA2-A21C-22B72D4EC731Q28070168-BBEBE910-C300-4F6B-9403-CB9121731030Q28070280-0E798570-B470-4F81-BD91-C2EC37177D0EQ28080225-4FD601D9-CA9C-4832-8D3D-E2837646DE66Q28082686-841FE073-DC6B-4A0F-A940-E76B2B664E5DQ28484313-024C0778-661A-4E28-802D-72B7AEE9A984Q28488938-A6E08A0E-CA32-481C-9800-BDED99290FD8Q28541478-8DE6C16D-0731-4E2F-9C72-D7E226B87A6FQ28543090-69B25CAD-1C29-4F64-8FE3-8215943A2B36Q28546718-36833879-A862-4703-8863-0F6EABBB800FQ28547529-1DD92CA4-7FC7-49EE-9441-5DB28C92F120Q28552246-5EB10B5E-A5EB-4319-9611-8DB25E60A6E0Q28741501-F32D83D0-BD61-41E2-A46D-92082038CF47Q30354346-F8033D07-54AC-4989-A198-5315B5329822Q30355947-BD10F9A4-D900-4C5A-9740-42E6668B3498Q30357059-9AE84E67-6532-4465-B833-2AC05DC53C43Q30358189-69D372AD-6A8C-4FB1-8F28-379D84D54F65Q30359561-3A41142F-2C73-4A61-BCFE-816A76C355F0Q30362068-AE5CAD55-F070-4B55-8BFF-1283A45A38E4Q30366572-629A44ED-8429-4ABD-B757-61A14B1E0546Q30374817-AB0F4553-FED7-42E5-BB3F-A9F4830DF401Q30375016-F400BF3C-22D3-4A98-8E00-2C3C66F0A097Q30378111-94FB8147-E79F-4E94-A301-FB4CB375E464Q30382172-3260FC8F-738C-47D2-A8F6-99A0CFB72CCCQ30386788-24CB16A9-8C7F-467F-A751-690B2DBC596EQ30397191-324926CA-B94E-4F6F-9795-68EFA850A534Q30407625-EC473FBA-7F49-4B94-A1CF-A5A56B82E958
P2860
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Development of a simple noninv ...... ents with HIV/HCV coinfection.
@en
Development of a simple noninv ...... ents with HIV/HCV coinfection.
@nl
type
label
Development of a simple noninv ...... ents with HIV/HCV coinfection.
@en
Development of a simple noninv ...... ents with HIV/HCV coinfection.
@nl
prefLabel
Development of a simple noninv ...... ents with HIV/HCV coinfection.
@en
Development of a simple noninv ...... ents with HIV/HCV coinfection.
@nl
P2093
P356
P1433
P1476
Development of a simple noninv ...... ents with HIV/HCV coinfection.
@en
P2093
APRICOT Clinical Investigators
David L Thomas
Diethelm Messinger
Doug T Dieterich
Eduardo Lissen
Francesca J Torriani
Mark Nelson
Mark S Sulkowski
Mendes Cassia Correa
Nathan Clumeck
P304
P356
10.1002/HEP.21178
P407
P577
2006-06-01T00:00:00Z